Share the post "Astec LifeSciences : Q1 2024 Financial Quarterly Report : YoY Sales Down 51.44 %, QoQ Down 54.88 %"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -51.44 % over the year, decrease in net sales/revenue by -54.88 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -45.93 %, Marginal decrease of -54.86% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Astec LifeSciences Limited. Notable increase of 385.16 % in net profit Year to Year, Astec LifeSciences Limited’s profitability increased by 4019.81 % in this quarter.
- EPS over the Year and quarter: EPS increased by 384.69 % Year to Year. EPS decreased by -4152 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 142.849 Cr | Rs. 153.748 Cr | Rs. 69.373 Cr | -54.88 % | -51.44 % |
Expenses | Rs. 139.72 Cr | Rs. 141.04 Cr | Rs. 115.63 Cr | -18.02 % | -17.24 % |
Operating Profit | Rs. 3.13 Cr | Rs. 12.71 Cr | Rs. -46.26 Cr | -463.97 % | -1577.96 % |
OPM % | 2.19 % | 8.27 % | -66.68 % | -74.95 % | -68.87 % |
Other Income | Rs. 1.709 Cr | Rs. 2.047 Cr | Rs. 0.924 Cr | -54.86 % | -45.93 % |
Interest | Rs. 6.46 Cr | Rs. 6.68 Cr | Rs. 7.04 Cr | + 5.39 % | + 8.98 % |
Depreciation | Rs. 9.39 Cr | Rs. 9.01 Cr | Rs. 9.27 Cr | + 2.89 % | -1.28 % |
Profit before tax | Rs. -11.01 Cr | Rs. -0.93 Cr | Rs. -61.65 Cr | -6529.03 % | -459.95 % |
Tax % | -25.63 % | -4.1 % | -35.57 % | -31.47 % | -9.94 % |
Net Profit | Rs. -8.19 Cr | Rs. -0.96 Cr | Rs. -39.72 Cr | -4037.5 % | -384.98 % |
EPS in Rs | Rs. -4.18 | Rs. -0.5 | Rs. -20.26 | -3952 % | -384.69 % |
Today, we’re looking at Astec LifeSciences Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -51.44 %. However, it did see a marginal slip of -54.88 % from the previous quarter. Expenses decreased slightly by -18.02 % quarter-on-quarter, aligning with the annual decline of -17.24 %. Operating profit, while down -1577.96 % compared to last year, faced a quarter-on-quarter dip of -463.97 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -68.87 %, but a shrinkage of -74.95 % sequentially. Other income fell by -54.86 % compared to the last quarter, despite an annual decline of -45.93 %. Interest expenses surged remarkably by 5.39 % from the previous quarter, yet the year-over-year increase remains at a moderate 8.98 %. Depreciation costs climbed by 2.89 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -1.28 %. Profit before tax declined annually by -459.95 % but saw a reduction from the preceding quarter by -6529.03 %.
Tax expenses as a percentage of profits decreased slightly by -9.94 % compared to last year, with a more notable quarter-on-quarter decrease of -31.47 %. Net profit fell by -384.98 % year-on-year but witnessed a -4037.5 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -384.69 % but a quarterly fall of -3952 %. In summary, Astec LifeSciences Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 142.849 Cr | Rs. 153.748 Cr | Rs. 69.373 Cr | -54.88 % | -51.44 % |
Expenses | Rs. 139.72 Cr | Rs. 141.04 Cr | Rs. 115.63 Cr | -18.02 % | -17.24 % |
Operating Profit | Rs. 3.13 Cr | Rs. 12.71 Cr | Rs. -46.26 Cr | -463.97 % | -1577.96 % |
Net Profit | Rs. -8.19 Cr | Rs. -0.96 Cr | Rs. -39.72 Cr | -4037.5 % | -384.98 % |
EPS in Rs | Rs. -4.18 | Rs. -0.5 | Rs. -20.26 | -3952 % | -384.69 % |
In reviewing Astec LifeSciences Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -51.44 % year-on-year, although there was a slight dip of -54.88 % from the previous quarter. Expenses decreased by -17.24 % compared to the previous year, with a decrease of -18.02 % quarter-on-quarter. Operating Profit dropped by -1577.96 % annually, and saw a -463.97 % decrease from the last quarter.
Net Profit showed yearly decrease of -384.98 %, and experienced a -4037.5 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -384.69 % annually, however dipped by -3952 % compared to the last quarter. In essence, while Astec LifeSciences Limited faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.